I-Mab’s Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes Aug 9, 2018 Life Science
Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B Financing Aug 8, 2018 Life Science
Harbour BioMed and Glenmark Pharmaceuticals Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers Aug 7, 2018 Life Science
Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China Aug 1, 2018 Life Science
